Risk factors and clinical features of infections caused by plasmid-mediated AmpC β-lactamase-producing Enterobacteriaceae

International Journal of Antimicrobial Agents

Volumn 34, Issue 1, 2009, Pages 38-43

  Park, Yoon Soo ^a   Yoo, Sunmi ^b   Seo, Mi Ran ^c   Kim, Jin Yong ^a   Cho, Yong Kyun ^a   Pai, Hyunjoo ^c  

^a Gachon University College of Medicine   (South Korea)

^b Inje University College of Medicine   (South Korea)

^c Hanyang University College of Medicine   (South Korea)

Author keywords

AmpC lactamase; Clinical features; Plasmid mediated; Risk factors

Indexed keywords

BETA LACTAMASE AMPC;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENTEROBACTERIACEAE INFECTION; ENZYME INHIBITION; ESCHERICHIA COLI; FEMALE; HUMAN; INFECTION RISK; ISOELECTRIC FOCUSING; KLEBSIELLA PNEUMONIAE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; TREATMENT FAILURE;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; CASE-CONTROL STUDIES; CLUSTER ANALYSIS; CROSS INFECTION; DNA, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; EPIDEMIOLOGY, MOLECULAR; FEMALE; GENOTYPE; HUMANS; ISOELECTRIC FOCUSING; MALE; MIDDLE AGED; PLASMIDS; RISK FACTORS; URINARY CATHETERIZATION;

EID: 67349111420     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2009.01.009     Document Type: Article

References (31)

1. Philippon A., Arlet G., and Jacoby G.A. Plasmid-determined AmpC-type β-lactamases. Antimicrob Agents Chemother 46 (2002) 1-11
2. Hanson N.D. AmpC β-lactamases: what do we need to know for the future?. J Antimicrob Chemother 52 (2003) 2-4
3. Yan J.J., Hsueh P.R., Lu J.J., Chang F.Y., Shyr J.M., Wan J.H., et al. Extended-spectrum β-lactamases and plasmid-mediated AmpC enzymes among clinical isolates of Escherichia coli and Klebsiella pneumoniae from seven medical centers in Taiwan. Antimicrob Agents Chemother 50 (2006) 1861-1864
4. Lee K., Lee M., Shin J.H., Lee M.H., Kang S.H., Park A.J., et al. Prevalence of plasmid-mediated AmpC β-lactamases in Escherichia coli and Klebsiella pneumoniae in Korea. Microb Drug Resist 12 (2006) 44-49
5. Song W., Kim J.S., Kim H.S., Yong D., Jeong S.H., Park M.J., et al. Increasing trend in the prevalence of plasmid-mediated AmpC β-lactamases in Enterobacteriaceae lacking chromosomal ampC gene at a Korean university hospital from 2002 to 2004. Diagn Microbiol Infect Dis 55 (2006) 219-224
6. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disc susceptibility tests; approved standard. 8th ed. Document M2-A8. Wayne, PA: NCCLS; 2003.
7. Mathew A., Harris A.M., Marshall M.J., and Ross G.W. The use of analytical isoelectric focusing for detection and identification of β-lactamases. J Gen Microbiol 88 (1975) 169-178
8. Pai H., Kang C.I., Byeon J.H., Lee K.D., Park W.B., Kim H.B., et al. Epidemiology and clinical features of bloodstream infections caused by AmpC-type-β-lactamase-producing Klebsiella pneumoniae. Antimicrob Agents Chemother 48 (2004) 3720-3728
9. Pai H., Choi E.-H., Lee H.-J., Hong J.Y., and Jacoby G.A. Identification of CTX-M-14 extended-spectrum β-lactamase in clinical isolates of Shigella sonnei, Escherichia coli, and Klebsiella pneumoniae in Korea. J Clin Microbiol 39 (2001) 3747-3749
10. Pai H., Lyu S., Lee J.H., Kim J., Kwon Y., Kim J.-W., et al. Survey of extended-spectrum β-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence of TEM-52 in Korea. J Clin Microbiol 37 (1999) 1758-1763
11. Silbert S., Pfaller M.A., Hollis R.J., Barth A.L., and Sader H.S. Evaluation of three molecular typing techniques for nonfermentative Gram-negative bacilli. Infect Control Hosp Epidemiol 25 (2004) 847-851
12. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., and Hughes J.M. CDC definitions for nosocomial infections, 1988. Am J Infect Control 16 (1988) 128-140
13. Friedman N.D., Kaye K.S., Stout J.E., McGarry S.A., Trivette S.L., Briggs J.P., et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137 (2002) 791-797
14. Lautenbach E., Patel J.B., Bilker W.B., Edelstein P.H., and Fishman N.O. Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 32 (2001) 1162-1171
15. Kang C.I., Kim S.H., Park W.B., Lee K.D., Kim H.B., Kim E.C., et al. Bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy. Antimicrob Agents Chemother 48 (2004) 4574-4581
16. Pena C., Pujol M., Ardanuy C., Ricart A., Pallares R., Linares J., et al. An outbreak of hospital-acquired Klebsiella pneumoniae bacteraemia, including strains producing extended-spectrum β-lactamase. J Hosp Infect 47 (2001) 53-59
17. Lin M.F., Huang M.L., and Lai S.H. Risk factors in the acquisition of extended-spectrum β-lactamase Klebsiella pneumoniae: a case-control study in a district teaching hospital in Taiwan. J Hosp Infect 53 (2003) 39-45
18. Kanafani Z.A., Mehio-Sibai A., Araj G.F., Kanaan M., and Kanj S.S. Epidemiology and risk factors for extended-spectrum β-lactamase-producing organisms: a case control study at a tertiary care center in Lebanon. Am J Infect Control 33 (2005) 326-332
19. Kang C.I., Kim S.H., Kim D.M., Park W.B., Lee K.D., Kim H.B., et al. Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum β-lactamase-producing Klebsiella pneumoniae. Infect Control Hosp Epidemiol 25 (2004) 860-867
20. Kim Y.K., Pai H., Lee H.J., Park S.E., Choi E.H., Kim J., et al. Bloodstream infections by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome. Antimicrob Agents Chemother 46 (2002) 1481-1491
21. Lee S.O., Lee E.S., Park S.Y., Kim S.Y., Seo Y.H., and Cho Y.K. Reduced use of third-generation cephalosporins decreases the acquisition of extended-spectrum β-lactamase-producing Klebsiella pneumoniae. Infect Control Hosp Epidemiol 25 (2004) 832-837
22. Bradford P.A., Urban C., Mariano N., Projan S.J., Rahal J.J., and Bush K. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the foss of an outer membrane protein. Antimicrob Agents Chemother 41 (1997) 563-569
23. Papanicolaou G.A., Medeiros A.A., and Jacoby G.A. Novel plasmid-mediated β-lactamase (MIR-1) conferring resistance to oxyimino- and α-methoxy β-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother 34 (1990) 2200-2209
24. Yan J.J., Ko W.C., Jung Y.C., Chuang C.L., and Wu J.J. Emergence of Klebsiella pneumoniae isolates producing inducible DHA-1 β-lactamase in a university hospital in Taiwan. J Clin Microbiol 40 (2002) 3121-3126
25. Yong D., Lim Y., Song W., Choi Y.S., Park D.Y., Lee H., et al. Plasmid-mediated, inducible AmpC β-lactamase (DHA-1)-producing Enterobacteriaceae at a Korean hospital: wide dissemination in Klebsiella pneumoniae and Klebsiella oxytoca and emergence in Proteus mirabilis. Diagn Microbiol Infect Dis 53 (2005) 65-70
26. Kang C.I., Kim S.H., Park W.B., Lee K.D., Kim H.B., Kim E.C., et al. Bloodstream infections caused by antibiotic-resistant Gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother 49 (2005) 760-766
27. Bauernfeind A., Chong Y., and Lee K. Plasmid-encoded AmpC β-lactamases: how far have we gone 10 years after the discovery?. Yonsei Med J 39 (1998) 520-525
28. Kim J., Kwon Y., Pai H., Kim J.W., and Cho D.T. Survey of Klebsiella pneumoniae strains producing extended-spectrum β-lactamases: prevalence of SHV-12 and SHV-2a in Korea. J Clin Microbiol 36 (1998) 1446-1449
29. CMY-2 among Escherichia coli isolates from food animals, retail ground meats, and humans in southern Taiwan. Antimicrob Agents Chemother 48 (2004) 1353-1356
30. Yan J.J., Ko W.C., Wu H.M., Tsai S.H., Chuang C.L., and Wu J.J. Complexity of Klebsiella pneumoniae isolates resistant to both cephamycins and extended-spectrum cephalosporins at a teaching hospital in Taiwan. J Clin Microbiol 42 (2004) 5337-5340
31. Kang C.I., Pai H., Kim S.H., Kim H.B., Kim E.C., Oh M.D., et al. Cefepime and the inoculum effect in tests with Klebsiella pneumoniae producing plasmid-mediated AmpC-type β-lactamase. J Antimicrob Chemother 54 (2004) 1130-1133